ArticleClinicoEconomics and outcomes research : CEOR2026

Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa.

Dejan Milentijevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.